PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NNOX vs. PGNY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NNOX and PGNY is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

NNOX vs. PGNY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nano-X Imaging Ltd. (NNOX) and Progyny, Inc. (PGNY). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2025February
-8.28%
8.22%
NNOX
PGNY

Key characteristics

Sharpe Ratio

NNOX:

0.03

PGNY:

-0.72

Sortino Ratio

NNOX:

0.96

PGNY:

-0.70

Omega Ratio

NNOX:

1.11

PGNY:

0.88

Calmar Ratio

NNOX:

0.03

PGNY:

-0.55

Martin Ratio

NNOX:

0.07

PGNY:

-0.99

Ulcer Index

NNOX:

41.26%

PGNY:

44.43%

Daily Std Dev

NNOX:

86.76%

PGNY:

61.60%

Max Drawdown

NNOX:

-94.44%

PGNY:

-79.49%

Current Drawdown

NNOX:

-92.68%

PGNY:

-65.81%

Fundamentals

Market Cap

NNOX:

$382.73M

PGNY:

$1.94B

EPS

NNOX:

-$0.86

PGNY:

$0.60

Total Revenue (TTM)

NNOX:

$8.28M

PGNY:

$868.79M

Gross Profit (TTM)

NNOX:

-$7.82M

PGNY:

$189.93M

EBITDA (TTM)

NNOX:

-$32.93M

PGNY:

$53.14M

Returns By Period

In the year-to-date period, NNOX achieves a -9.17% return, which is significantly lower than PGNY's 32.12% return.


NNOX

YTD

-9.17%

1M

-22.24%

6M

-8.27%

1Y

-49.50%

5Y*

N/A

10Y*

N/A

PGNY

YTD

32.12%

1M

8.52%

6M

8.21%

1Y

-44.11%

5Y*

-7.54%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NNOX vs. PGNY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NNOX
The Risk-Adjusted Performance Rank of NNOX is 4949
Overall Rank
The Sharpe Ratio Rank of NNOX is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of NNOX is 5656
Sortino Ratio Rank
The Omega Ratio Rank of NNOX is 5353
Omega Ratio Rank
The Calmar Ratio Rank of NNOX is 4545
Calmar Ratio Rank
The Martin Ratio Rank of NNOX is 4545
Martin Ratio Rank

PGNY
The Risk-Adjusted Performance Rank of PGNY is 1515
Overall Rank
The Sharpe Ratio Rank of PGNY is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of PGNY is 1515
Sortino Ratio Rank
The Omega Ratio Rank of PGNY is 1111
Omega Ratio Rank
The Calmar Ratio Rank of PGNY is 1414
Calmar Ratio Rank
The Martin Ratio Rank of PGNY is 2222
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NNOX vs. PGNY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Nano-X Imaging Ltd. (NNOX) and Progyny, Inc. (PGNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NNOX, currently valued at 0.03, compared to the broader market-2.000.002.004.000.03-0.72
The chart of Sortino ratio for NNOX, currently valued at 0.96, compared to the broader market-6.00-4.00-2.000.002.004.006.000.96-0.70
The chart of Omega ratio for NNOX, currently valued at 1.11, compared to the broader market0.501.001.502.001.110.88
The chart of Calmar ratio for NNOX, currently valued at 0.03, compared to the broader market0.002.004.006.000.03-0.55
The chart of Martin ratio for NNOX, currently valued at 0.07, compared to the broader market0.0010.0020.0030.000.07-0.99
NNOX
PGNY

The current NNOX Sharpe Ratio is 0.03, which is higher than the PGNY Sharpe Ratio of -0.72. The chart below compares the historical Sharpe Ratios of NNOX and PGNY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50SeptemberOctoberNovemberDecember2025February
0.03
-0.72
NNOX
PGNY

Dividends

NNOX vs. PGNY - Dividend Comparison

Neither NNOX nor PGNY has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NNOX vs. PGNY - Drawdown Comparison

The maximum NNOX drawdown since its inception was -94.44%, which is greater than PGNY's maximum drawdown of -79.49%. Use the drawdown chart below to compare losses from any high point for NNOX and PGNY. For additional features, visit the drawdowns tool.


-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%-65.00%-60.00%SeptemberOctoberNovemberDecember2025February
-92.68%
-65.81%
NNOX
PGNY

Volatility

NNOX vs. PGNY - Volatility Comparison

Nano-X Imaging Ltd. (NNOX) has a higher volatility of 21.06% compared to Progyny, Inc. (PGNY) at 9.96%. This indicates that NNOX's price experiences larger fluctuations and is considered to be riskier than PGNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
21.06%
9.96%
NNOX
PGNY

Financials

NNOX vs. PGNY - Financials Comparison

This section allows you to compare key financial metrics between Nano-X Imaging Ltd. and Progyny, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab